• FirefoxInstall the new Firefox »
  •  Dow Up0.21% Nasdaq Up0.32%

    More On AEZS



    News & Info


    Analyst Coverage


    • Major Holders
    • Insider Transactions
    • Insider Roster


    Aeterna Zentaris Inc. (AEZS)

    0.79 Down 0.05(6.05%) Mar 5, 3:59PM EST
    |After Hours : 0.69 Down 0.10 (12.78%) Mar 5, 7:59PM EST
    Add to Portfolio
    ProfileGet Profile for:
    Aeterna Zentaris Inc.
    1405 du Parc-Technologique Boulevard
    Quebec City, QC G1P 4P5
    Canada - Map
    Phone: 418-652-8525
    Fax: 418-948-9191
    Website: http://www.aezsinc.com

    Index Membership:N/A
    Full Time Employees:N/A

    Business Summary 

    Aeterna Zentaris Inc., a specialty biopharmaceutical company, is focused on developing and commercializing novel treatments in oncology and endocrinology. The company’s product pipeline includes MACRILEN, for which a New Drug Application is under review by the FDA as an oral product used for evaluating adult growth hormone deficiency. MACRILEN is also investigated in a Phase 2A clinical trial to treat cancer-induced cachexia. Its product pipeline also comprises zoptarelin doxorubicin, which is in the ZoptEC (zoptarelin doxorubicin in Endometrial Cancer) Phase 3 trial in women with advanced, recurrent, or metastatic endometrial cancer. In addition, the company’s preclinical product candidates in oncology include AEZS-120, a live recombinant oral tumor vaccine candidate; PI3K/Erk inhibitors, including AEZS-129 and AEZS-136; and disorazol Z product candidates, such as AEZS-137 and AEZS-138. Aeterna Zentaris Inc. was founded in 1991 and is headquartered in Quebec City, Canada.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Aeterna Zentaris Inc.

    Key Executives 
    Mr. David Alan Dodd , 65
    Chairman, Chief Exec. Officer and Pres
    Mr. Dennis Turpin CPA, CA,
    Chief Financial Officer and Sr. VP
    Mr. Jude Dinges ,
    Chief Commercial Officer and Sr. VP
    Dr. Richard Sachse M.D., Ph.D.,
    Chief Scientific Officer, Chief Medical Officer and Sr. VP
    Mr. Philip A. Theodore , 62
    Chief Admin. Officer, Sr. VP, Gen. Counsel and Corp. Sec.
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.